ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways. The company was founded in 2021 and is headquartered in Nissequogue, New York.
Org chart
President and Chief Executive Officer
Collapse
Chief Operating Officer
Scientific Co-Founder and Senior Scientific Advisor
